Highnoon Laboratories Limited (PSX:HINOON)
Pakistan · Delayed Price · Currency is PKR 1,036.72
+7.86 (0.76%)
At close: Apr 17, 2026
Highnoon Laboratories Revenue
In the year 2025, Highnoon Laboratories had annual revenue of 27.71B PKR with 12.44% growth. Highnoon Laboratories had revenue of 7.40B in the quarter ending December 31, 2025, with 17.18% growth.
Revenue
27.71B
Revenue Growth
+12.44%
P/S Ratio
1.98
Revenue / Employee
11.66M
Employees
2,563
Market Cap
54.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 27.71B | 3.06B | 12.44% |
| Dec 31, 2024 | 24.64B | 4.87B | 24.66% |
| Dec 31, 2023 | 19.77B | 3.95B | 24.98% |
| Dec 31, 2022 | 15.82B | 2.82B | 21.65% |
| Dec 31, 2021 | 13.00B | 2.30B | 21.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 75.40B |
| GlaxoSmithKline Pakistan | 65.90B |
| The Searle Company | 33.26B |
| AGP Limited | 28.89B |
| Ferozsons Laboratories | 22.22B |
| Citi Pharma | 14.10B |
| Macter International | 11.58B |
| Otsuka Pakistan | 4.26B |